Name: Latest research reports of Zydus Lifesciences Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Zydus Lifesciences Ltd.
Rating: 3
Author: Motilal Oswal

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

978.5000 -1.10 (-0.11%)

NSE Jul 14, 2025 10:19 AM

26.11% Fall from 52W High

Volume: 288.8K

Zydus Lifesciences Ltd.

09 Jan 2024

978.50

-0.11%

Efforts underway to improve growth prospects for key markets

Neutral: Zydus Lifesciences Ltd.

Target

Motilal Oswal

Zydus Lifesciences L.. has an average target of 988.60 from 5 brokers.